Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.08.12.248393v1?rss=1 Authors: Siddiqui, J. K., Miles, W. O. Abstract: Immunotherapy has improved the prognosis for half of the melanoma patients, prompting a need to understand differences between responding and non-responding patients. Gene expression profiling of tumors has focused on deriving primarily immune-related signatures, however these have shown limited predictive power. Recent studies have highlighted the role of RNA editing in modulating resistance to immunotherapy. This has led us to test whether RNA editing activity can be predictive of response in publicly available datasets of immunotherapy-treated melanoma patients. Here, we identified RNA editing signatures that were able to predict with very high accuracy and confidence patient responses and outcomes. Our analysis, however, demonstrates that RNA editing by itself is sufficient as a strong predictive tool for examining sensitivity of melanoma patients to immunotherapy. Copy rights belong to original authors. Visit the link for more info